The Royal Marsden NHS Foundation Trust has examined how messenger RNA (mRNA) technology is reshaping the future of cancer vaccines. Reported via Oncodaily on November 5, 2026, the discussion highlights the evolving role of mRNA applications in oncology. While detailed clinical data and specific trial metrics were not provided in the source text, the development underscores the ongoing medical focus on utilizing mRNA platforms to potentially advance cancer treatment and vaccine development.